TGFB1 and diabetes mellitus: The results showed that blockade of IL-10/TGF-β bioactivities in vivo dramatically abrogated the suppressive effects of p524-expanded CD4+CD25+ T cells on adoptively transfer of diabetes (Figure 4b).